Resources Repository
-
ReportPublication 2016Modeling to Inform Strategies to Improve Population Health
This workshop report summarizes a workshop convened by the Institute of Medicine to explore the potential …
This workshop report summarizes a workshop convened by the Institute of Medicine to explore the potential uses of simulation and other types of modeling for improving health. Participants worked to identify how modeling could inform population health decision making (selecting and refining potential strategies, ranging from interventions to investments) based on lessons learned from models that have been, or have not been, used successfully, opportunities and barriers to incorporating models into decision making, and data needs and…
Dynamic Simulation | Mathematical Models | Decision Analysis | Health/Medicine | State-Transition | Microsimulation | Chronic Disease/Risk | Environmental Health | Health Systems | Policy/Regulation | Business/Industry | Climate/Environment | Government/Law | North America -
ReportPublication 2015Modeling to Improve Policy Decisions in the Americas: Noncommunicable Diseases
In the Region of the Americas, noncommunicable diseases (NCDs) are a clear threat not only …
In the Region of the Americas, noncommunicable diseases (NCDs) are a clear threat not only to human health, but also to a country’s economic development and growth. The evidence on both of these counts is compelling. In 2012, cardiovascular disease, diabetes, cancers, chronic respiratory conditions including asthma, and other NCDs were the cause of 4.5 million deaths in the Americas. Of that total number, 1.5 million of them were premature, occurring among people aged 30-69…
Mathematical Models | Cost-Effectiveness Analysis | Decision Analysis | Health/Medicine | Priority Setting/Ethics | Costing Methods | State-Transition | Microsimulation | Chronic Disease/Risk | Mental Health | Latin America & Caribbean -
EditorialPublication 2020Waiting for Certainty on COVID-19 Antibody Tests — At What Cost?
This perspective anticipates the availability of serologic antibody testing and considers its potential usefulness in mitigation …
This perspective anticipates the availability of serologic antibody testing and considers its potential usefulness in mitigation policy to reduce COVID-19 transmission. For example: Could we screen for serologic antibodies as a proxy for possible immunity and identify people who could return to the workplace with less severe mitigation measures? The authors acknowledge the uncertainties raised by many policy actors, including the WHO, such as, "Do antibodies confer immunity and, if so, for how long? How accurate is…
Probability/Bayes | Technology Assessment | Health/Medicine | Test Performance | Infectious Diseases | Health Systems | Policy/Regulation | Government/Law | Global | North America -
ReportPublication 2015Chapter 4: Cervical Cancer
This chapter focuses on the possibility of primary prevention of cervical cancer as a result …
This chapter focuses on the possibility of primary prevention of cervical cancer as a result of the introduction of two commercially available vaccines against human papillomavirus (HPV). Few low- and middle-income countries (LMICs) have initiated or sustained cytology-based cervical cancer prevention programs, and these countries experience very high incidence and mortality rates. Fortunately, alternative strategies to prevent cervical cancer have been investigated and extensively evaluated in these settings. The authors report findings from cost-effectiveness analyses…
Mathematical Models | Cost-Effectiveness Analysis | Health/Medicine | Infectious Diseases | Chronic Disease/Risk | Health Systems | Clinical Care | Science/Technology | Global -
ReportPublication 2015Opioid Dependence: Final Report
This report from the Institute for Clinical and Economic Review (ICER) examines the comparative effectiveness and value …
This report from the Institute for Clinical and Economic Review (ICER) examines the comparative effectiveness and value of interventions for the management of opioid dependence. The goals of the report are to document the federal and New England state regulations affecting treatment options, provide an overview of existing clinical guidelines and payer coverage policies, and summarize the evidence on the different management approaches for opioid dependence, including special considerations for adolescents. An appendix is provided by ICER.…
Technology Assessment | Cost-Effectiveness Analysis | Health/Medicine | Preferences/Values | Health Outcomes | Evidence Synthesis | Chronic Disease/Risk | Mental Health | Health Systems | Policy/Regulation | Business/Industry | Government/Law | Science/Technology | North America -
EditorialPublication 2023Societal Perspective: Themed Issue on Productivity Costs, Consumption Costs, Informal Care Costs
Economic evaluations in healthcare assess the costs and benefits of new interventions, particularly pharmaceuticals, to …
Economic evaluations in healthcare assess the costs and benefits of new interventions, particularly pharmaceuticals, to inform funding and reimbursement decisions. These evaluations compare a new intervention against a relevant comparator, with the relevance of costs and benefits depending on the chosen perspective. The healthcare perspective, which assumes a fixed budget and aims to maximize health outcomes, considers only health impacts and costs within the budget. This approach simplifies the evaluation but may lead to suboptimal…
Cost-Effectiveness Analysis | Health/Medicine | Costing Methods -
ReportPublication 2022Investment Case for New Tuberculosis Vaccines
Investing more financial resources to accelerate scientific progress toward an effective tuberculosis (TB) vaccine will …
Investing more financial resources to accelerate scientific progress toward an effective tuberculosis (TB) vaccine will save lives, fight antimicrobial resistance, advance health equity, improve economic growth, and bring a substantial return on investment. This World Health Organization (WHO) report describes the full value proposition for new TB vaccines. These analyses articulate the broader economic impacts of new TB vaccines to guide global stakeholders when making investment decisions for novel TB vaccines and to plan for…
Cost-Effectiveness Analysis | Health/Medicine | Infectious Diseases | Economics/Finance | Global -
EditorialPublication 2021Scientific and Regulatory Challenges in Designing mHealth Interventions
Scientists looking for innovative ways to deliver health care have long searched for mechanisms that …
Scientists looking for innovative ways to deliver health care have long searched for mechanisms that can enable the right intervention to be delivered at the right time. Traditional delivery mechanisms have been limited both to the availability of a provider (e.g., a physician) and the location of care (e.g., a hospital or outpatient clinic). In recent years, however, numerous technological advancements—including wearable devices, mobile technologies, and the widespread development and use of user-friendly smartphone applications—have…
Technology Assessment | Health/Medicine | Science/Technology | North America -
ReportPublication 2022Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement
The article introduces the CHEERS 2022 statement, an updated set of guidelines for reporting health …
The article introduces the CHEERS 2022 statement, an updated set of guidelines for reporting health economic evaluations. Health economic evaluations compare alternative actions in terms of costs and consequences. The original CHEERS statement, published in 2013, aimed to make these evaluations clear, interpretable, and useful for decision-making by providing a standardized reporting format. Methods involved reviewing advancements in health economic evaluation methods and the need for inclusive stakeholder engagement, including patients and the public. The…
Cost-Effectiveness Analysis | Health/Medicine